T-cell-mediated tumor cell killing in PD-L1/KO H460 cells and the wild-type control H460 cells was evaluated by Giemsa staining after PD-L1 antibody treatment, with or without pretreatment by MMC. This evidence concerns the gene CD274 and neoplasm.